We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.14B
AUM Growth
+$78M
Cap. Flow
+$4.03M
Cap. Flow %
0.35%
Top 10 Hldgs %
49.37%
Holding
304
New
70
Increased
124
Reduced
70
Closed
7

Top Buys

Rank Stock Value
1
AVUV icon
Avantis US Small Cap Value ETF
AVUV
+$3.94M
2
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$3.93M
3
NMRA icon
Neumora Therapeutics
NMRA
+$3.31M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$2.97M
5
MSFT icon
Microsoft
MSFT
+$2.45M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$16M
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$5.85M
3
JMST icon
JPMorgan Ultra-Short Municipal Income ETF
JMST
+$3.04M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$2.44M
5
EW icon
Edwards Lifesciences
EW
+$2.12M

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.4%
2 Technology 5.18%
3 Healthcare 2.32%
4 Financials 1.59%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHEL icon
226
Shell
SHEL
$250B
$261K 0.02%
3,891
-788
-17% -$50.5K
CI icon
227
Cigna
CI
$73.7B
$259K 0.02%
+712
New +$234K
L icon
228
Loews
L
$22.4B
$256K 0.02%
+3,268
New +$242K
RSPT icon
229
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.89B
$255K 0.02%
7,240
– –
SAN icon
230
Banco Santander
SAN
$213B
$254K 0.02%
52,508
+11,902
+29% +$49.7K
ARW icon
231
Arrow Electronics
ARW
$10.4B
$254K 0.02%
+1,963
New +$230K
GSK icon
232
GSK
GSK
$102B
$253K 0.02%
+5,913
New +$244K
FITB
233
Fifth Third Bancorp
FITB
$49.5B
$253K 0.02%
6,800
-52
-0.8% -$1.81K
DHR icon
234
Danaher
DHR
$152B
$252K 0.02%
+1,011
New +$247K
IBM icon
235
IBM
IBM
$222B
$252K 0.02%
+1,320
New +$241K
SNY icon
236
Sanofi
SNY
$107B
$251K 0.02%
+5,167
New +$252K
PSTX
237
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$251K 0.02%
78,580
+2,021
+3% +$6.74K
CDNS icon
238
Cadence Design Systems
CDNS
$93.7B
$250K 0.02%
+803
New +$238K
ING icon
239
ING
ING
$101B
$248K 0.02%
15,049
+4,796
+47% +$68.5K
MDLZ icon
240
Mondelez International
MDLZ
$79.6B
$247K 0.02%
+3,528
New +$258K
CB icon
241
Chubb
CB
$131B
$247K 0.02%
+953
New +$234K
NET icon
242
Cloudflare
NET
$107B
$245K 0.02%
2,526
+32
+1% +$2.9K
ELV icon
243
Elevance Health
ELV
$85.5B
$243K 0.02%
+469
New +$233K
IG icon
244
Principal Investment Grade Corporate Active ETF
IG
$202M
$243K 0.02%
11,762
– –
NKE icon
245
Nike
NKE
$58.7B
$239K 0.02%
2,539
+326
+15% +$33.2K
T icon
246
AT&T
T
$178B
$238K 0.02%
+13,537
New +$231K
OTIS icon
247
Otis Worldwide
OTIS
$27.3B
$237K 0.02%
2,390
-10
-0.4% -$924
UNM icon
248
Unum
UNM
$14.7B
$237K 0.02%
+4,412
New +$215K
ISRG icon
249
Intuitive Surgical
ISRG
$132B
$236K 0.02%
+591
New +$223K
PXH icon
250
Invesco FTSE RAFI Emerging Markets ETF
PXH
$2.01B
$233K 0.02%
11,986
– –
8 9
10
11 12

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Callan Capital held 304 positions worth $1.14B, up 7.4% from $1.06B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Callan Capital's Q1 2024 filing shows 70 new, 124 increased, 70 reduced and 7 closed positions. Its largest new stake was Neumora Therapeutics: 204,987 shares worth $2.82M. The largest sale was NVIDIA, an estimated $16M.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 88% a quarter earlier, followed by Technology and Healthcare.

  • Callan Capital's largest Q1 2024 buy was Neumora Therapeutics: 204,987 shares worth $2.82M.
  • Callan Capital added most to Avantis US Small Cap Value ETF in Q1 2024, an estimated $3.94M increase.
  • Callan Capital's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $16M.
  • Callan Capital fully exited Edwards Lifesciences in Q1 2024, selling an estimated $2.12M.
  • Callan Capital's ten largest holdings make up 49% of its $1.14B portfolio in Q1 2024.
  • Callan Capital opened 70 new positions and closed 7 in Q1 2024.
  • Callan Capital's portfolio value rose 7.4% quarter-over-quarter to $1.14B.

Based on Callan Capital's 13F filing for Q1 2024, filed 3 May 2024.